TMX2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.618600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.481600E-02
Normal-vs-Stage2
2.674800E-01
Normal-vs-Stage3
8.556000E-01
Normal-vs-Stage4
3.210400E-01
Stage1-vs-Stage2
4.895000E-01
Stage1-vs-Stage3
2.673600E-01
Stage1-vs-Stage4
3.043200E-01
Stage2-vs-Stage3
3.569000E-01
Stage2-vs-Stage4
8.022400E-01
Stage3-vs-Stage4
6.739000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.961200E-01
Normal-vs-AfricanAmerican
8.708100E-02
Normal-vs-Asian
2.294600E-01
Caucasian-vs-AfricanAmerican
7.261500E-02
Caucasian-vs-Asian
8.692400E-01
AfricanAmerican-vs-Asian
1.528030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.837000E-01
Normal-vs-Female
2.444800E-01
Male-vs-Female
8.518200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.645200E-01
Normal-vs-Age(41-60Yrs)
8.007900E-02
Normal-vs-Age(61-80Yrs)
4.161000E-01
Normal-vs-Age(81-100Yrs)
1.842160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.595600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.507600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.929200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.169970E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.341600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.372600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.453400E-01
Normal-vs-Daily Drinker
3.738000E-01
Normal-vs-Weekly Drinker
5.016800E-01
Normal-vs-Occasional Drinker
6.568400E-02
Normal-vs-Social Drinker
2.170400E-01
Non Drinker-vs-Daily Drinker
4.915600E-01
Non Drinker-vs-Weekly Drinker
7.962600E-01
Non Drinker-vs-Occasional Drinker
9.990400E-02
Non Drinker-vs-Social Drinker
3.835200E-01
Daily Drinker-vs-Weekly Drinker
3.840000E-01
Daily Drinker-vs-Occasional Drinker
3.844800E-01
Daily Drinker-vs-Social Drinker
8.436600E-01
Weekly Drinker-vs-Occasional Drinker
3.663800E-02
Weekly Drinker-vs-Social Drinker
2.267200E-01
Occasional Drinker-vs-Social Drinker
4.712600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.156200E-01
Normal-vs-Grade 2
9.419800E-02
Normal-vs-Grade 3
3.471600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.107200E-01
Grade 1-vs-Grade 3
1.932450E-02
Grade 1-vs-Grade 4
6.156200E-01
Grade 2-vs-Grade 3
1.833580E-01
Grade 2-vs-Grade 4
9.419800E-02
Grade 3-vs-Grade 4
3.471600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.342400E-01
Normal-vs-NonDiabetic
2.184000E-01
Diabetic-vs-NonDiabetic
1.625790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.215800E-02
Normal-vs-NoPancreatitis
3.264600E-01
Pancreatitis-vs-NoPancreatitis
1.390280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.299820E-01
Normal-vs-N1
3.133600E-01
N0-vs-N1
4.294600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.896270E-02
Normal-vs-TP53-NonMutant
3.342400E-01
TP53-Mutant-vs-TP53-NonMutant
2.559700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
